跳至主要内容
临床试验/IRCT20180205038626N9
IRCT20180205038626N9招募中2 期

Comparison the short-term outcomes of Ticagrelor versus Clopidogrel treatment in patients with myocardial infarction undergoing Percutaneous Coronary Intervention

Rasht University of Medical Sciences0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 years and older
  • Chest pain that lasts more than 20 minutes and no response to nitroglycerin
  • Patients with PCI were underwent PCI less than 12 hours from the onset of symptoms.
  • The ST segment rises more than 1 mm in at least two or more limb leads.
  • The ST segment is more than 2 mm high in two or more precordial leads.

排除标准

  • Cardiogenic shock in the form of systolic blood pressure less than 90 to 60 mm Hg and did not respond to hydration therapy
  • Thrombolysis in the last 24 hours
  • Recent anticoagulant therapy or recent use of P2Y12 antagonist
  • Contraindications to aspirin, clopidogrel and ticagrelor
  • History of coronary artery bypass grafting in recent year
  • Patient dissatisfaction

研究者

发起方
Rasht University of Medical Sciences

相似试验